香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於香港註冊成立的有限公司） （股份代號：3329） 於2025年12月17日舉行之股東特別大會 投票表決結果 股東特別大會投票表決結果 茲提述交銀國際控股有限公司（「本公司」）日期為2025年11月28日的通函（「通函」）及股 東特別大會（「股東特別大會」）通告（「股東特別大會通告」）。除文義另有所指外，本公 告所用詞彙與通函所界定者具有相同涵義。 本公司董事會（「董事會」）欣然宣佈，股東特別大會通告所載之決議案（「決議案」）已於 2025年12月17日（星期三）上午十一時正舉行的股東特別大會上以投票方式獲正式通過。 決議案之投票表決結果如下： | | 普通決議案 | 票數(%) | | | --- | --- | --- | --- | | | | 贊成 | 反對 | | 1. | 批准、追認及確認自動重續物業租賃框架協議的年期至 | 145,785,167 | 1,000 | | | 截至2028 ...

Group 1 - The core viewpoint of the article indicates that the domestic power battery installation volume in November continues to grow, with exports remaining stable [1] - According to the China Automotive Power Battery Industry Innovation Alliance, the domestic power battery installation volume reached 93.5 GWh in November 2025, representing a year-on-year increase of 39.2% and a month-on-month increase of 11.2% [1] - The report suggests that battery production in December will continue to grow month-on-month, presenting an opportunity for investment in the lithium battery sector following recent adjustments [1] Group 2 - Data from Xinluo Lithium Battery indicates that the planned battery production for domestic sample enterprises in December is 148.8 GWh, reflecting a month-on-month increase of 2.3%, while overseas sample enterprises plan for 23.8 GWh, showing a month-on-month decline of 2.6% [1] - The industry fundamentals are described as robust, with ongoing production increases, suggesting that the recent sector pullback may provide a window for investment [1] - The report highlights the importance of focusing on companies with cost and technological advantages, particularly mentioning CATL (Ningde Times) as a leader in overseas expansion [1]

Core Viewpoint - Expanding domestic demand is the top priority for the next year, with a focus on boosting consumption and investment to sustain economic growth [1] Group 1: Domestic Demand and Economic Growth - Domestic demand has remained stable overall, contributing 71% to economic growth in the first three quarters of the year [1] - Recent months have seen a slowdown in consumption and investment growth, indicating the need for continued efforts to expand domestic demand [1] Group 2: Consumption Trends - Consumption is expected to see a slight recovery in 2025, with a moderate growth trend anticipated to continue into 2026 [1] - The core characteristic of this new normal is a slower overall demand growth, but rational consumption and an upward shift in demand levels are driving structural differentiation, which will become a significant growth driver in niche markets [1] Group 3: Investment Opportunities - Investors may consider the Zhongzheng A500 ETF (159338), which is compiled using an internationally recognized "industry balance" method [1] - As of the 2025 mid-year report, the total number of accounts for the Guotai Zhongzheng A500 ETF ranks first among its peers, being more than three times that of the second place [1]

Group 1 - The core initiative of the Bank of Communications is the establishment of a Wealth Management Department to enhance its wealth management services and align with the national strategy for common prosperity [1][3] - The "Wode Wealth Nationwide Tour" is the first marketing project following the organizational restructuring, aiming to expand wealth management services from key regions to the entire country [1][6] - The tour will connect major economic zones including the Yangtze River Delta, Guangdong-Hong Kong-Macao Greater Bay Area, and Beijing-Tianjin-Hebei, promoting the bank's wealth management services [1][3] Group 2 - The bank's branches in the Guangdong-Hong Kong-Macao area have developed strong cross-border financial service capabilities, aiming to support the region's development as a world-class city cluster [3][6] - Experts at the event discussed macroeconomic outlooks, with insights on the long-term appreciation of the RMB against the USD due to various economic factors [4][6] - The event featured discussions on cross-border wealth management, emphasizing the need for lower account opening thresholds to facilitate global asset allocation for clients [5][6] Group 3 - The bank plans to conduct over 50 events nationwide in the next six months, including product strategy meetings and investment report sessions, to foster wealth growth and economic development [7][8] - The Hong Kong branch reported a 13% year-on-year increase in managed assets, highlighting the growing demand for offshore family trusts among clients in the Greater Bay Area [7][8] - The bank will collaborate with over 80 financial institutions to provide insights on macro trends and asset allocation strategies to clients [8]

新一代核心宽基A500ETF基金（512050）助力投资者布局A股核心资产、高效捕捉市场增长红利。该 ETF精准跟踪中证A500指数，指数采用"行业均衡配置+龙头优选"双策略，涵盖A股行业龙头，兼顾价 值与成长，实现对各细分领域的均衡配置。超配AI产业链、医药生物、电网设备新能源等新质生产力 赛道，形成天然哑铃型投资结构。该基金具备三大核心亮点：费率低廉（综合费率0.2%），流动性充 裕（近一月日均成交超50亿元），规模领先（超200亿元），是把握A股估值提升机遇的高效投资选 择。 （文章来源：每日经济新闻） 中国经济增长韧性与政策成效获得广泛认可。IMF宣布将2025年中国经济增速预期上调0.2个百分点至 5%，指出中国推出的一系列宏观政策举措是上调预期的关键，预计未来几年中国对全球经济增长的贡 献率将保持在30%左右。世界银行最新将2025年中国经济增长预测上调0.4个百分点至4.9%，认为中国 更积极的财政政策、适度宽松的货币政策以及出口市场的多元化，共同支撑了国内消费、投资与出口的 韧性。同时，高盛、德意志银行和渣打银行近期纷纷上调中国2025年及未来的GDP增速预测。 交银国际证券表示，2025年全 ...

Group 1 - The core viewpoint of the article is that the Federal Reserve has reduced interest rates by 25 basis points to a range of 3.5-3.75%, marking the third consecutive rate cut since September, following a "preventive rate cut + risk management" policy framework [1] - The outlook suggests that the Federal Reserve is likely to adopt a "wait-and-see, then decide" approach at the beginning of next year, indicating a pause in rate cuts once employment and inflation data are more reliable [1] - Overall, the meeting reinforced the signal that there will be no rate hikes, but also no continuous rate cuts, while the RMP-style balance sheet expansion is expected to provide a technical buffer for the interest rate market and liquidity, benefiting the recovery of risk assets [1]

交银国际发布研报称，予内地科技行业领先评级。报告指，最近一个月，全球科技指数表现呈现分化， 存储价格继续飙升，该行维持预计供不应求的趋势或将延续至2026年底。半导体制造设备进口额10月同 比保持高速增长26%。该行继续看好内地半导体设备的投资前景并维持2026年市场规模较2025年继续增 长4.2%至542亿美元的预测。 该行认为全球AI基础设施过度建设的潜在风险总体可控，并看好2026年AI基础设施相关的投资前景。 相对于可比公司，NVIDIA(NVDA.US)近期股价表现相对滞后。该行认为该股在AI算力领域的主导地位 没有改变。该行看好半导体国产替代产业链机会，重点推荐北方华创（002371）(002371.SZ)和豪威集 团（603501）(603501.SH)。 ...

Summary of Key Points from the Conference Call Industry Overview - **Industry**: Real Estate - **Focus**: Chinese mainland and Hong Kong real estate markets - **Outlook for 2026**: The industry is expected to explore new development models under strong policy support, despite facing challenges. Structural opportunities from "good houses" and "good cities" are emerging [1][6][10]. Core Insights and Arguments Chinese Mainland Real Estate - **Sales Forecast**: The total sales area of commercial housing in China is projected to be between 900 million to 950 million square meters in 2026, down from approximately 970 million square meters in 2024. The expected sales amount is around 10 to 11 trillion RMB, including 8 to 9 trillion RMB from residential sales [1][11]. - **Investment Preference**: The preferred investment ranking is as follows: state-owned enterprises (SOEs) or SOE-backed developers > leading private enterprises with land reserves in first and second-tier cities > other private developers [1][26]. - **Market Dynamics**: The market is transitioning from quantity expansion to quality improvement, with a focus on "good housing" standards. The demand is shifting towards improvement-type housing, which is expected to dominate the market [10][13]. Hong Kong Real Estate - **Market Recovery**: Key catalysts for recovery include improved macroeconomic uncertainty (notably interest rate cuts), significant policy easing, and a return of fundamental demand drivers. The recovery is expected to be gradual, with residential properties leading the way, followed by quality retail assets and core office spaces [3][37]. - **Rental Growth**: Residential rents are expected to increase by approximately 3% in 2026, with small to medium-sized unit prices rising by 5%. The retail sector is also anticipated to see moderate growth due to stabilizing local consumption and increased tourist arrivals [3][39]. - **Investment Strategy**: Investors are advised to focus on residential recovery as a high-quality proxy, particularly in the context of the anticipated market rebound [3][37]. Additional Important Insights - **Policy Environment**: The current policy framework is expected to remain supportive, with a focus on maintaining a stable demand-side policy and normalizing supply-side regulations. The emphasis is on improving housing quality and service standards [10][12]. - **Market Segmentation**: The market is experiencing significant segmentation, with first and second-tier cities showing resilience while third and fourth-tier cities face structural adjustments. The share of sales in first and strong second-tier cities is expected to increase from 30% to 35-40% by 2026 [12][15]. - **Supply Dynamics**: New construction is projected to be between 550 million to 600 million square meters in 2026, reflecting cautious market expectations and cash flow conditions among developers. This is expected to help digest existing inventory levels [21][22]. - **Financial Health of Developers**: The industry is shifting towards a focus on cash flow management, with a significant emphasis on achieving positive operating cash flow as a key indicator of operational capability. Developers with strong cash flow management are likely to be favored by the market [24][25]. Conclusion The real estate industry in both the Chinese mainland and Hong Kong is at a pivotal point, with emerging opportunities driven by policy support and changing market dynamics. Investors are encouraged to adopt a selective approach, focusing on quality and location to capitalize on the anticipated recovery in the sector [25][26].

Summary of the Conference Call Transcript Industry Overview - **Industry**: Consumer Sector - **2025 Performance**: The consumer market in mainland China has shown a mild recovery, with a year-on-year growth of 4.3% in retail sales from January to October 2025, indicating a steady recovery path [1][6][29]. - **2026 Outlook**: The consumer market is expected to continue its moderate growth, characterized by slower overall demand growth but increasing rational consumption and demand tiering, which will drive structural differentiation and become a key growth driver in niche markets [1][6][7]. Key Insights Consumer Behavior - **Consumer Confidence**: The consumer confidence index has gradually improved but remains below the neutral level of 100, indicating cautious consumer sentiment regarding future income and employment [7][13]. - **Spending Trends**: Consumers are increasingly focused on value for money and emotional value, with a high willingness to pay for emotional experiences, which is reshaping brand competition [26][31][32]. Market Dynamics - **Segment Performance**: Different segments are recovering at varying paces. Categories like home appliances, jewelry, and food staples have shown strong growth, while others like dining and personal care have seen slight declines [23][62]. - **Channel Evolution**: The integration of online and offline channels is deepening, with online growth slightly outpacing offline. New retail formats are emerging, focusing on consumer-centric approaches [37][28]. Technological Impact - **AI Integration**: Artificial intelligence is increasingly being integrated into various industry segments, enhancing operational efficiency and potentially reshaping competitive dynamics [49][50]. Investment Strategy - **2026 Investment Focus**: A balanced strategy is recommended, combining defensive sectors with stable cash flows and high-growth potential opportunities. Key sectors to focus on include: - Defensive companies benefiting from supply-demand improvements, such as Shenzhou (2313 HK) and Yili (600887 CH) [56]. - Fast-growing niche leaders like Pop Mart (9992 HK) and Miniso (9896 HK) [56]. - Industry leaders with strong growth foundations and resilience, such as Anta (2020 HK) and China Resources Beer (291 HK) [56]. Risks - **Macro Uncertainties**: Potential risks include macroeconomic uncertainties, commodity inflation exceeding expectations, international trade uncertainties, and insufficient consumer stimulus policies [57]. Additional Insights - **Emerging Trends**: The rise of emotional consumption is driving growth in categories like trendy toys and cultural products, with brands leveraging IP ecosystems for rapid revenue growth [68][70]. - **Global Expansion**: Chinese consumer brands are increasingly looking to expand internationally, particularly in Southeast Asia, to tap into new growth opportunities [35][36]. This summary encapsulates the key points from the conference call, highlighting the current state and future outlook of the consumer sector, along with strategic investment recommendations and associated risks.

Summary of the Conference Call on the Pharmaceutical Industry Industry Overview - **Industry**: Pharmaceutical Industry - **Rating**: Leading - **2026 Outlook**: Value recovery, upward trend continues, selective layout amidst differentiation [1] Core Insights and Arguments - **Industry Trends**: - The industry is expected to maintain a relatively fast growth rate despite tightening drug regulations and increasing challenges in new drug development in the U.S. [2] - The integration trend within the industry is just beginning, with leading players in high-growth segments showing strong long-term certainty [2] - **Private Hospitals**: - High-quality private hospital targets are recommended as cost control pressures ease and outdated capacities are eliminated, allowing for a return to faster growth [3] - Recommended stocks include Gushengtang and Haijia Medical, which are expected to rebound in the short term and have clear long-term expansion paths [3] - **Valuation Summary**: - A detailed table of various pharmaceutical companies with their stock codes, ratings, target prices, closing prices, earnings per share (EPS), price-to-earnings ratios (P/E), and other financial metrics is provided [4] Important but Overlooked Content - **Market Performance**: - The MSCI China Pharmaceutical Index increased by 62.0% year-to-date, outperforming the MSCI China Index by 31.8 percentage points [10] - The pharmaceutical sector has officially entered a rebound phase, with significant performance differentiation among sub-sectors [10] - **Policy Environment**: - The policy environment is improving, with the government supporting innovative drug development and introducing commercial insurance funds to supplement the medical insurance directory [11] - The latest round of medical insurance negotiations has successfully included 127 drugs outside the directory, indicating a shift towards a more balanced pricing strategy [11] - **Innovation and R&D**: - The industry is witnessing a positive cycle of R&D breakthroughs and global licensing, with many companies entering a "R&D investment - clinical breakthrough - global licensing" cycle [11] - As of September 2025, Chinese pharmaceutical companies have completed 103 overseas transactions, exceeding 77% of the total transaction amount for 2024 [11] - **Financial Performance**: - The overall revenue of the A-share pharmaceutical sector showed a marginal recovery in Q3 2025, with a 0.7% year-on-year increase, indicating strong operational resilience [17] - The sector's earnings growth expectations are improving, with leading companies showing rapid recovery in performance [11][20] - **Investment Opportunities**: - The report emphasizes two main investment lines: focusing on innovative companies with strong differentiation and product export potential, and capitalizing on the recovery of valuation multiples and earnings growth [32][34] - Specific recommendations include companies like Sanofi Pharmaceutical, Deqi Pharmaceutical, and Baiji Shenzhou, which have rich catalysts and are still undervalued [35] - **AI in Healthcare**: - The application of AI in healthcare is highlighted as a new theme for industry innovation, with significant market expansion potential [33] - **Future Outlook**: - The pharmaceutical industry is expected to maintain a stable upward trend in 2026, with a focus on fundamental performance and valuation [30] - The introduction of the commercial insurance innovative drug directory and ongoing policy reforms are anticipated to further enhance market sentiment and fundamental expectations [37]